Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.
Ena Respiratory has raised $22.4M in total funding. The most recent round was Series B. The last funding was announced in October 2025.
Ena Respiratory's investors include Bill & Melinda Gates Foundation, Brandon Capital, Uniseed, U.S. Department of Defense, Hostplus.
Ena Respiratory is headquartered in Melbourne, Australia.
Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.
Ena Respiratory is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ena Respiratory — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/ena-respiratory. Accessed July 20, 2026.
VCBacked. (2025). Ena Respiratory — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/ena-respiratory
{{cite web |title=Ena Respiratory — Funding & Investors |url=https://www.vcbacked.co/company/ena-respiratory |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated